Share this
Uber Closes SoftBank Investment
Personal Shopping Service Stitch Fix Raises $120 Million in IPO
Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes
Aridis – $26 Million IPO
Medivation Agrees to Sell to Pfizer for $14 Billion
Uber to Buy Self-Driving Truck Startup Otto
Advaxis – $30 Million Registered Direct Offering
Gemphire Therapeutics – $30 Million IPO
Syros – $58 Million IPO
Syros IPO – $58 Million
Inotek Pharmaceuticals – $50 Million Follow-On
Syndax – $58 Million IPO
AveXis – $95 Million IPO
Atlassian - $531 Million IPO
Voyager Therapeutics - $80.5 Million IPO
Strongbridge Biopharma IPO
NantKwest IPO - $238 Million IPO
ProNAi Therapeutics - $158 Million IPO
Ooma Prices $65 Million IPO
NantKwest – $238 Million IPO
Catabasis Completes $69 Million IPO
ProNAi – $158 Million IPO
NVIDIA Secures $380 Million Synthetic Lease for New Headquarters
MINDBODY Completes $100 Million IPO
HTG Completes its Initial Public Offering
Apigee Completes Initial Public Offering
Jawbone Acquisition of Body Media
KemPharm Completes its IPO
Cidara Completes Initial Public Offering
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
Rovi Corporation Completes $345 Million Convertible Note Offering
Invitae Completes $117 Million Initial Public Offering
Ascendis Pharma closes $124 million IPO
Bellicum Pharmaceuticals $160 million IPO
TRACON Pharmaceuticals Completes Initial Public Offering
New Relic Completes $132 Million Initial Public Offering
Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes
Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes
Xenon Pharmaceuticals Completes Initial Public Offering
Atara – $63 Million IPO and Follow-On Offerings
Vascular Biogenics Prices IPO
Demira Prices $125 Million IPO
T2 Biosystems IPO
Jazz Pharmaceuticals plc Rule 144A Offering of $575 Million of Exchangeable Senior Notes
Otonomy $100 Million IPO
Immune Design $63 Million Initial Public Offering
HealthEquity $146 Million Initial Public Offering
Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering
Minerva Neurosciences $32.7 Million IPO
Kite Pharma $146 Million Initial Public Offering
Zendesk's $115 Million Initial Public Offering
Alder Biopharmaceuticals $80 Million Initial Public Offering
TriVascular Initial Public Offering
Vital Therapies Initial Public Offering
Cooley Advises Underwriters on Vital Therapies IPO
Aerohive Networks $75 Million IPO
TriNet – $276 million IPO and $352 million follow-on
Castlight Health's $204 Million IPO
Amedica Initial Public Offering
Auspex $96 Million Initial Public Offering
Egalet Corporation IPO
Eleven Biotherapeutics IPO
Trevena $64 Million Initial Public Offering
Cooley Advises Auspex on its Initial Public Offering
First US IPO of 2014 for GlycoMimetics
Five Prime Therapeutics IPO
LinkedIn's $1.25 Billion Follow-On Offering
Onconova Therapeutics IPO
Epizyme, Inc. Initial Public Offering
Portola Pharmaceuticals $140 Million IPO
Ambit Initial Public Offering
Cyan, Inc. Initial Public Offering
Receptos, Inc. Initial Public Offering
Cooley Advises Ambit on its IPO
Insys Therapeutics IPO
Minerva – $58 Million Follow-On Offering
Redfin – $159 Million IPO